ClearBridge Investments
AERI

ClearBridge Investments’s Aerie Pharmaceuticals AERI Stock Holding History

ClearBridge Investments’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-871,200
Closed -$9.93M – 818
2021
Q3 		$9.93M Sell
871,200
-82,576
-9% -$1.21M 0.01% 571
2021
Q2 		$15.3M Sell
953,776
-4,122
-0.4% -$70.7K 0.01% 557
2021
Q1 		$17.1M Buy
957,898
+315,655
+49% +$5.45M 0.01% 514
2020
Q4 		$8.68M Buy
642,243
+9,050
+1% +$109K 0.01% 559
2020
Q3 		$7.45M Sell
633,193
-2,982
-0.5% -$36.3K 0.01% 550
2020
Q2 		$9.39M Buy
636,175
+27,480
+5% +$407K 0.01% 517
2020
Q1 		$8.22M Sell
608,695
-4,056
-0.7% -$77K 0.01% 499
2019
Q4 		$14.6M Buy
612,751
+205,421
+50% +$4.25M 0.01% 502
2019
Q3 		$7.83M Buy
+407,330
New +$9.33M 0.01% 561

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

ClearBridge Investments's AERI Position: Q4 2021 in Review

ClearBridge Investments sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 871,200 shares — an estimated $9.93M sold.

ClearBridge Investments first reported a position in AERI in Q3 2019 and held it in 9 quarters. The position peaked at $17.1M in Q1 2021. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

  • ClearBridge Investments reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • ClearBridge Investments sold 871,200 Aerie Pharmaceuticals shares in Q4 2021, an estimated $9.93M.
  • ClearBridge Investments first reported a position in Aerie Pharmaceuticals in Q3 2019 and held it in 9 quarters.
  • ClearBridge Investments's Aerie Pharmaceuticals position peaked at $17.1M in Q1 2021.
  • 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on ClearBridge Investments's 13F filing for Q4 2021, filed 11 Feb 2022.